(Q35116259)

6 August 2017

1 reference

title

Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy (English)

1 reference

invasive fungal infections

6 August 2017

main subject

1 reference

inferred from title

immunocompromised host

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718828

28 December 2023

1

Emmanuel Roilides

1 reference

6 August 2017

3

Evangelia Farmaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718828

28 December 2023

author name string

Cristina Gil Lamaignere

2

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12718828

28 December 2023

publication date

1 September 2002

1 reference

full work available at URL

6 August 2017

https://doi.org/10.1016/s1201-9712(02)90104-9

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718828

https://api.elsevier.com/content/article/PII:S1201971202901049?httpAccept=text/xml

28 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

https://api.elsevier.com/content/article/PII:S1201971202901049?httpAccept=text/plain

28 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

International Journal of Infectious Diseases

28 December 2023

published in

1 reference

6 August 2017

volume

6

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

154-163

1 reference

Predictors of adverse outcome in cancer patients with candidemia

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Cure of murine candidiasis by recombinant soluble interleukin-4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

A TH1-TH2-like switch in candidiasis: new perspectives for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Perspectives on the use of cytokines in the management of infectious complications of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Pulmonary host defences against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Th1 and Th2 cytokines in mice with invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Interferon- and Tumor Necrosis Factor- Protect Mice from Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Clinical patterns of Fusarium infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: report of a case in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Defective Interferon Gamma Production in Neonatal T Cells Is Independent of Interleukin-2 Receptor Binding

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Effects of macrophage colony-stimulating factor on antifungal activity of neonatal monocytes against Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Invasive aspergillosis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Helper T-cell responses in children infected with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

A Phase III Study of Recombinant Human Interferon Gamma to Prevent Opportunistic Infections in Advanced HIV Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Treatment of acute myeloid leukemia with cytokines: effect on duration of neutropenia and response to infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind contro

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Interferon gamma and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

A Randomized Clinical Trial of Granulocyte Transfusions for Infection in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Modulation of Neutrophil‐Mediated Activity Against the Pseudohyphal Form ofCandida albicansby Granulocyte Colony‐Stimulating Factor (G‐CSF) Administered In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

In vivo effects of macrophage colony-stimulating factor on human monocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990104-9

7 January 2021

Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon

15

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood

28 December 2023

36

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice

28 December 2023

52

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients

28 December 2023

79

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

The role of immunoreconstitution in the management of refractory opportunistic fungal infections

28 December 2023

81

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon

28 December 2023

92

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(02)90104-9

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference